Category Prescribing & medicines
Showing: Guidance Everything, including news and events
Topics:Collective action & GPCContracts & fundingPCNs & neighbourhoodsVaccinations & screeningPrescribing & medicinesReferrals & hospital servicesPublic healthIT, data & cyber securityWorkforce & employmentCQC, regulation & governancePCSE & patient registrationFees & non-NHS workPremises & estatesWellbeing & supportBLMC news
Oxybutynin 5mg tablets shortage
Oxybutynin 5mg immediate-release tablets were in short supply until about 31 July 2026. Guidance covers switching to modified-release tablets.
Class 2 recall: ramipril 2.5mg capsules (Crescent Pharma)
A precautionary recall of one batch of ramipril 2.5mg capsules after a pack was found to contain 10mg capsules. For primary care clinicians.
Nutricia Homeward: deliveries only with a prescription from 9 June
From 9 June 2026, Nutricia Homeward delivers enteral feeding products only once a prescription has been received.
Referring and prescribing guidance for children and young people’s gender care
Guidance on referral and prescribing for children and young people's gender care, clarifying primary care's role.
Reminder: availability of alternatives to Levemir ahead of discontinuation
Reminder to switch patients from Levemir before stock runs out in December 2026.
BMA goes ahead with GP collective action escalation ‘putting care ahead of cost savings’
The BMA's June escalation asked GPs to switch off medicines optimisation software.
GPs to ‘remove or ignore’ medicines optimisation software in contract dispute escalation
GPs asked to "remove or ignore" medicines optimisation software as collective action escalated (see BLMC's local advice).
Better visibility of repeat medicines in the NHS App
Patients can now see all their active repeat medicines in the NHS App, with reasons why some can't be requested yet.
Over one million switched to combined asthma inhalers since NICE update
Over a million asthma patients have switched to combination reliever inhalers since NICE's update.